Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

Discontinuing statins near the end of life is safe, improves patient quality of life

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer

Inhibition of PD-L1 using drug MPDL3280A for patients with metastatic urothelial bladder cancer

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

ASCO 2014 roundup

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence